About   Help   FAQ
Phenotypes associated with this allele
Allele Symbol
Allele Name
Allele ID
Leprtm3.1Yli
targeted mutation 3.1, Yong Liu
MGI:4820542
Summary 2 genotypes
Jump to Allelic Composition Genetic Background Genotype ID
hm1
Leprtm3.1Yli/Leprtm3.1Yli B6.129-Leprtm3.1Yli MGI:4820764
ht2
Leprtm3.1Yli/Lepr+ B6.129-Leprtm3.1Yli MGI:4820763


Genotype
MGI:4820764
hm1
Allelic
Composition
Leprtm3.1Yli/Leprtm3.1Yli
Genetic
Background
B6.129-Leprtm3.1Yli
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Leprtm3.1Yli mutation (0 available); any Lepr mutation (122 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
growth/size/body
• exhibited accelerated body weight gain with more rapid body fat accumulation, developing marked adultonset obesity with >10% higher body fat mass after the age of 35 weeks for males and 30 weeks for females
• homozygous animals at younger ages were slightly leaner than their WT counterparts until reaching comparable body weight and adiposity levels at the age of around 15 weeks

adipose tissue
• exhibited accelerated body weight gain with more rapid body fat accumulation, developing marked adultonset obesity with >10% higher body fat mass after the age of 35 weeks for males and 30 weeks for females
• homozygous animals at younger ages were slightly leaner than their WT counterparts until reaching comparable body weight and adiposity levels at the age of around 15 weeks

homeostasis/metabolism
• male mice at the age of 39 weeks had moderately but significantly increased serum levels of glucose and insulin in the fasted state in comparison with WT littermates
• mutant mice fed the high-fat diet for 13 weeks displayed higher degrees of hyperleptinemia and hyperinsulinemia than their WT counterparts
• In parallel with the age-dependent changes in their adiposity levels, male homozygous mice exhibited hyperleptinemia at the age of 39 weeks but displayed hypoleptinemia at 7 weeks in comparison with age-matched WT animals
• in parallel with the age-dependent changes in their adiposity levels, male homozygous mice exhibited hyperleptinemia at the age of 39 weeks but displayed hypoleptinemia at 7 weeks in comparison with age-matched WT animals
• mutant mice fed the high-fat diet for 13 weeks displayed higher degrees of hyperleptinemia and hyperinsulinemia than their WT counterparts
• In comparison with WT animals, male mutant mice, through a 12-hour light/dark cycle, showed markedly reduced oxygen consumption rates over the light and dark cycles at 48 weeks of age and, conversely, significantly higher oxygen consumption rates at 7 weeks of age.
• Female mice at 50 weeks of age also displayed significantly lower oxygen consumption rates as well as dramatically reduced activities, but they had comparable metabolic rates and physical activity at 7 weeks of age.
• mutant mice fed the high-fat diet for 9 weeks exhibited a significantly decreased metabolic rate and physical activity through the dark cycle relative to their WT littermates
• In comparison to WT animals, repeated intraperitoneal injection of leptin resulted in significantly less body weight reduction in 40-week-old male mutant mice, paralleled by insignificant appetite suppression
• 7-week-old mutant animals exhibited appreciably greater body weight reductions with similar decreases in food intake upon leptin treatment

behavior/neurological
• both male and female homozygous mice at 48 weeks of age exhibited considerably increased food intake; whereas 8-week-old males consumed significantly less food
• males at the age of 48 weeks exhibited a tendency of decreased activity, whereas at the age of 7 weeks they showed an 2-fold increase in physical activity through the dark cycle
• Female mice at 50 weeks of age also displayed significantly lower oxygen consumption rates as well as dramatically reduced activities, but they had comparable metabolic rates and physical activity at 7 weeks of age.
• mutant mice fed the high-fat diet for 9 weeks exhibited a significantly decreased metabolic rate and physical activity through the dark cycle relative to their WT littermates




Genotype
MGI:4820763
ht2
Allelic
Composition
Leprtm3.1Yli/Lepr+
Genetic
Background
B6.129-Leprtm3.1Yli
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Leprtm3.1Yli mutation (0 available); any Lepr mutation (122 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
growth/size/body
• both male and female heterozygous mice displayed the same tendency of age-dependent increases in body fat mass, with intermediate degrees of adiposity observed at 51 weeks of age compared to WT and homozygous animals

adipose tissue
• both male and female heterozygous mice displayed the same tendency of age-dependent increases in body fat mass, with intermediate degrees of adiposity observed at 51 weeks of age compared to WT and homozygous animals





Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
11/12/2024
MGI 6.24
The Jackson Laboratory